IDEAYA Biosciences, Inc.
Clinical-stage firm developing precision cancer therapies via synthetic lethality.
IDYA | US
Overview
Corporate Details
- ISIN(s):
- US45166A1025
- LEI:
- Country:
- United States of America
- Address:
- 5000 SHORELINE CT, SUITE 300, 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.ideayabio.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapeutics for cancer patients. The company specializes in an approach called synthetic lethality, an emerging class of precision medicine that targets cancer cells by exploiting their specific genetic vulnerabilities. IDEAYA utilizes molecular diagnostics to identify and select patient populations for its potential first-in-class or best-in-class therapies. Its integrated capabilities cover the full development spectrum, from target and biomarker discovery to clinical trials, employing small molecule and protein degrader therapeutic platforms to address unmet needs in oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all IDEAYA Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IDEAYA Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IDEAYA Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
